Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era89
Skin and soft tissue infections in the elderly39
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV39
Editorial introductions38
Strongyloidiasis-related lung involvement: too much of a bad thing36
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes35
From diagnosis to management: current perspectives on congenital cytomegalovirus infection33
Surgical management of cystic echinococcosis of the liver33
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel33
Complexities of cardiomyopathy in septic shock29
Corticosteroids for viral central nervous system infections29
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians28
La Crosse virus encephalitis in children28
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside27
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management26
Typhoid fever control in the 21st century: where are we now?25
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients25
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response25
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?24
New therapies for nontuberculous mycobacterial lung infection24
Progress and challenges in human papillomavirus and cervical cancer in southern Africa24
Fusarium species central nervous system infection24
Viral meningitis and encephalitis: an update23
Mycobacterial skin infection23
Malaria in pregnancy: baby steps22
Resistant herpes simplex virus infections – who, when, and what's new?22
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies21
Tuberculosis molecular bacterial load assay in the management of tuberculosis21
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention21
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?20
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli20
Using antibiotics wisely19
How coronavirus disease will change the face of travel medicine19
Tick-borne encephalitis19
Diagnostic stewardship: what impacts antibiotics use?19
Mpox in people living with HIV19
Editorial introductions18
Does climate change threaten delivery of HIV care in resource-limited settings?18
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis17
Global health security as it pertains to Zika, Ebola, and COVID-1917
Gut microbiome and its clinical implications: exploring the key players in human health17
Prevention strategies for congenital cytomegalovirus infection16
Diagnostic approach and update on encephalitis16
Risk stratification for selecting empiric antibiotherapy during and after COVID-1916
CMV antiviral stewardship in transplantation – the next frontier16
Appropriate surgical management in skin and soft tissue infections16
Emerging treatment options for cryptosporidiosis15
Immunotherapeutic approaches to HIV cure and remission15
The microbiota in respiratory tract infections: from association to intervention15
The impact of coronavirus disease 2019 on people with HIV15
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles15
Update on the treatment of chronic pulmonary aspergillosis15
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy14
The plumbing problem: rising antimicrobial resistance in building water systems14
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV14
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination14
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1913
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections13
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change13
Interpreting and managing preservation fluids positive for Gram-negative bacteria12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae12
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management12
Childhood tuberculosis12
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities12
Editorial introductions12
Editorial: Pathogenesis and immune response – editorial12
Update on drug treatments for multidrug resistant tuberculosis12
An overview of risk factors, management and prevention of cochlear implant infections11
Short treatment duration for community-acquired pneumonia11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients11
The disease burden of respiratory syncytial virus in Infants11
Respiratory metagenomics: route to routine service11
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives11
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?11
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis10
Novel techniques in the treatment of skin and soft tissue infection10
A new era of HIV care for age-associated multimorbidity10
The microbiome as a biomarker of anal precancerous lesions in people with HIV10
Neurobrucellosis10
Short-course antibiotic strategies for ventilator-associated pneumonia10
Identifying patients with difficult-to-treat acute bacterial skin infections10
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans10
The role of Gram-negative bacteria in skin and soft tissue infections10
Urinary tract infections in immunocompromised patients9
Antibiotic treatment of acute bacterial skin and skin structure infections9
Editorial introductions9
The evolution of knowledge for treating Gram-negative bacterial infections9
Skin and soft tissue infections in solid organ transplants9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
Chagas disease in the immunocompromised host9
Burden of influenza in the elderly: a narrative review9
Immune responses and severe dengue: what have we learned?9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
0.52005505561829